Phase I Finasteride Photosensitization Study in Healthy Males v1.0

• Research type

  Research Study

• Full title

  A Within-subject, Randomized, Evaluator-blinded, Vehicle-controlled Study to Assess the Photosensitization Potential of Finasteride Cutaneous Solution (P-3074) in Human Subjects

• IRAS ID

  196340

• Contact name

  Michael Carr

• Contact email

  jobroyd@princetonconsumer.com

• Sponsor organisation

  Polichem S.A.

• Eudract number

  2015-004564-11

• Clinicaltrials.gov Identifier

  NCT02791243

• Clinicaltrials.gov Identifier

  N/A, N/A

• Duration of Study in the UK

  0 years, 2 months, 11 days

• Research summary

  This study is being conducted to determine the potential of the topical study drug (0.25% Finasteride) to induce allergic skin responses when exposed to UVA/UVB artificial light and to monitor the study subjects for adverse reactions to exposure to the drug.

• REC name

  London - London Bridge Research Ethics Committee

• REC reference

  16/LO/0342

• Date of REC Opinion

  21 Mar 2016

• REC opinion

  Further Information Favourable Opinion